Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001628280-26-046653

CEO and President sold 10,000 shares at $16.01 ($160,080)

  • CEO and President acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Stengone Carmine N. CEO and President 2026-06-30 Option exercise 10b5-1 +7,500 $1.01 $7,575 24,717 D
Stengone Carmine N. CEO and President 2026-06-30 Option exercise 10b5-1 +2,500 $1.26 $3,150 27,217 D
Stengone Carmine N. CEO and President 2026-06-30 Sale 10b5-1 −10,000 $16.01 $160,080 17,217 D
Derivatives
Stengone Carmine N. CEO and President 2026-06-30 Option exercise · Stock Option (right to buy) 10b5-1 −7,500 281,930 D
Stengone Carmine N. CEO and President 2026-06-30 Option exercise · Stock Option (right to buy) 10b5-1 −2,500 118,417 D
Open-market sales · 10,000 sh · avg $16.01 · $160,080
Loading xslF345X06/wk-form4_1782947042.xml…